Abstract
Granulocyte colony-stimulating factor (G-CSF) has been shown to support the growth of multipotential hematopoietic stem cells in addition to the cells of neutrophilic lineage. Philadelphia chromosome (Ph1)-positive leukemia has its origin in the hematopoietic stem cell. In the present study, we demonstrated that the proliferation of leukemic cells from chronic myeloid leukemia in blast crisis (CML-BC) and Ph1-positive acute lymphoblastic leukemia (ALL) cases is frequently stimulated with G-CSF in vitro. We next studied a total of 12 leukemic cell lines established from CML-BC (n = 6) and Ph1-positive acute leukemia (n = 6): four ‘myeloid’, five ‘biphenotypic’, and three ‘lymphoid’ types. All cell lines expressed G-CSF receptor (G-CSFR) in flow cytometric analysis, but their proliferative response to G-CSF in 3H-thymidine incorporation assay varied. The ‘biphenotypic’ cell lines expressed G-CSFR at higher levels and showed the most pronounced response to G-CSF. The ‘lymphoid’ cell lines showed intermediate G-CSFR expression with the modest response to G-CSF. Unexpectedly, ‘myeloid’ cell lines showed lower G-CSFR expression and lower G-CSF response compared with ‘biphenotypic’ cell lines. In three of four ‘myeloid’ cell lines, proliferation was partially inhibited by an addition of anti-G-CSF neutralizing monoclonal antibody into culture medium. Further, the % inhibition of 3H-thymidine uptake of cell lines positively correlated with the amount of their intracellular G-CSF measured by enzyme immunoassay, suggesting an autocrine growth mechanism via the G-CSF/G-CSFR interaction. These results suggest that G-CSF play an important role in the growth regulation of leukemia cells from Ph1-positive acute leukemia and CML-BC.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Nagata S, Tsuchiya M, Asano S, Kaziro Y, Yamazaki T, Yamamoto O, Hirata Y, Kubota N, Oheda M, Nomura H, Ono M . Molecular cloning and expression of cDNA for human granulocyte colony-stimulating factor Nature 1986 319: 415–418
Ohno R, Tomonaga M, Kobayashi T, Kanamaru A, Shirakawa S, Masaoka T, Omine M, Oh H, Nomura T, Sakai Y, Hirano M, Yokomaku S, Nakayama S, Yoshida Y, Miura A, Morishita Y, Dohy H, Niho Y, Hamajima N, Takaku F . Effect of granulocyte colony-stimulating factor after intensive induction therapy in relapsed or refractory acute leukemia New Engl J Med 1990 323: 871–877
Sieff CA . Hematopoietic growth factors J Clin Invest 1987 79: 1549–1556
Budel LM, Touw IP, Delwel R, Lowenberg B . Granulocyte colony-stimulating factor receptors in human acute myelocytic leukemia Blood 1989 74: 2668–2673
Kondo S, Okamura S, Asanom Y, Harada M, Niho Y . Human granulocyte colony-stimulating factor receptors in acute myelogenous leukemia Eur J Haematol 1991 46: 223–230
Motoji T, Watanabe M, Uzumaki H, Kusaka M, Fukamachi H, Shimosaka A, Oshimi K, Mizoguchi H . Granulocyte colony-stimulating factor (G-CSF) receptors on acute myeloblastic leukaemia cells and their relationship with the proliferative response to G-CSF in clonogenic assay Br J Haematol 1991 77: 54–59
Piao Y, Okabe T . Receptor binding of human granulocyte colony-stimulating factor to the blast cells of myeloid leukemia Cancer Res 1990 50: 1671–1674
Shimoda K, Okamura S, Harada N, Ikematu W, Kondo S, Kawasaki C, Tanaka T, Etou T, Akashi K, Okamura T, Shibuya T, Harada M, Niho Y . Granulocyte colony-stimulating factor receptors on human acute leukemia: biphenotypic leukemic cells possess granulocyte colony-stimulating factor receptors Cancer Res 1992 52: 3052–3055
Baer MR, Bernstein SH, Brunetto VL, Heinonen K, Mrozek K, Swann VL, Minderman H, Block AW, Pixley LA, Christiansen NP, Fay JW, Barcos M, Rustum Y, Herzig GP, Bloomfield CD . Biological effects of recombinant human granulocyte colony-stimulating factor in patients with untreated acute myeloid leukemia Blood 1996 87: 1484–1490
Ikebuchi K, Clark SC, Ihle JN, Souza LM, Ogawa M . Granulocyte colony-stimulating factor enhances interleukin 3-dependent proliferation of multipotential hematopoietic progenitors Proc Natl Acad Sci USA 1988 85: 3445–3449
Metcalf D, Nicola NA . Proliferative effects of purified granulocyte colony-stimulating factor (G-CSF) on normal mouse hemopoietic cells J Cell Physiol 1983 116: 198–206
Mizoguchi H, Suda T, Miura Y, Kubota K, Takaku F . Hemopoietic stem cells in nude mice transplanted with colony-stimulating-factor-producing tumors Exp Hematol 1982 10: 874–879
Inukai T, Sugita K, Iijima K, Goi K, Tezuka T, Kojika S, Kagami K, Mori T, Kinosita A, Suzuki T, Okazaki-Koyama T, Nakazawa S . Leukemic cells with 11q23 translocations express granulocyte colony-stimulating factor (G-CSF) receptor and their proliferation is stimulated with G-CSF Leukemia 1998 12: 382–389
Chen SJ, Flandrin G, Daniel MT, Valensi F, Baranger L, Grausz D, Bernheim A, Chen Z, Sigaux F, Berger R . Philadelphia-positive acute leukemia: lineage promiscuity and inconsistently rearranged breakpoint cluster region Leukemia 1988 2: 261–267
Fialkow PJ, Jacobson RJ, Papayannopoulou T . Chronic myelocytic leukemia: clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage Am J Med 1977 63: 125–129
Fialkow PJ, Denman AM, Lacobson RJ, Lowenthal MN . Chronic myelocytic leukemia: origin of some lymphocytes from leukemic stem cells J Clin Invest 1978 62: 815–820
Jonas D, Lubbert M, Kawasaki ES, Henke M, Bross KJ, Mertelsmann R, Herrmann F . Clonal analysis of bcr-abl rearrangement in T lymphocytes from patients with chronic myelogenous leukemia Blood 1992 79: 1017–1022
Nakazawa S, Saito M, Okazaki T, Takane K, Sugita K, Mori T, Nishino K, Suzuki T, Kinoshita A, Abe T, Kurosawa Y, Inukai T . Immunological classification of childhood acute lymphoblastic leukemia Acta Pediatr Jpn 1991 33: 507–521
Tachibana N, Raimondi SC, Lauer SJ, Sartain P, Dow LW . Evidence for a multipotential stem cell disease in some childhood Philadelphia chromosome-positive acute lymphoblastic leukemia Blood 1987 70: 1458–1461
Crist W, Carroll A, Shuster J, Jackson J, Head D, Borowitz M, Behm F, Link M, Steuber P, Ragab A, Hirt A, Brock B, Land V, Pullen J . Philadelphia chromosome positive childhood acute lymphoblastic leukemia: clinical and cytogenetic characteristics and treatment outcome. A Pediatric Oncology Group study Blood 1990 76: 489–495
Tsuchiya H, Adachi N, Asou N, Takatsuki K, Matuda I, Kawano F, Murakami T, Mizutani S, Watanabe M . Responses to granulocyte colony-stimulating factor (G-CSF) and granulocyte-macrophage CSF in Ph1-positive acute lymphoblastic leukemia with myeloid surface markers Blood 1991 77: 411–412
Tatsumi N, Yamane T, Tsuda I, Okuda K, Chaisiripoomkere W . Flow cytometric detection of recombinant human granulocyte-colony stimulating factor binding to leukemic cells J Clin Lab Ana 1993 7: 86–90
Andersson LC . Induction of erythroid differentiation in the human leukemic cell line K562 Nature 1979 279: 364–366
LeBien TW, Hozier J, Minowada J, Kersey H . Origin of chronic myelocytic leukemia in a precursor of pre-B lymphocytes New Engl J Med 1979 301: 144–148
Nakamura M, Sugita K, Inukai T, Goi K, Iijima K, Tezuka T, Kojika S, Shiraishi K, Miyamoto N, Karakida N, Kagami K, Okazaki-Koyama T, Mori T, Nakazawa S . p16/MTS1/INK4A gene is frequently inactivated by hypermethylation in childhood acute lymphoblastic leukemia with 11q23 translocation Leukemia 1999 13: 884–890
Mori T, Nakazawa S, Nishino K, Sugita K, Takane K, Mori M, Sagawa K, Hayashi Y, Sakurai M . Ph1-positive CML-derived myeloid-monocytoid precursor cell line producing substance(s) that stimulates normal CFU-C Leukemia Res 1987 11: 241–249
Inukai T, Sugita K, Suzuki T, Ijima K, Goi K, Tezuka T, Kojika S, Hatakeyama K, Kagami K, Mori T, Okazaki T, Mizutani S, Nakazawa S . A novel 203KD aberrant BCR-ABL product in a girl with Philadelphia chromosome positive acute lymphoblastic leukemia Br J Haematol 1993 85: 823–825
Nakazawa S, Saito M, Sugita K, Okazaki T, Suzuki T, Mizutani S, Hayashi Y . Establishment of two cell lines (biphenotypic and myelomonocytic) derived from a patient with Ph1 positive acute leukemia Proc 81st AACR Meeting 1990 206: (Abstr.)
Inukai T, Saito M, Mori T, Nishino K, Abe T, Kinoshita A, Suzuki T, Kurosawa Y, Okazaki T, Sugita K, Nakazawa S . Analysis of cytoplasmic and surface antigens in childhood T-cell acute lymphoblastic leukemias: clinical relevance of cytoplasmic TCRβ chain expression Br J Haematol 1994 87: 273–281
Sugita K, Nakazawa S, Mori T, Nishino K, Abe T, Kinoshita A, Suzuki T, Saito M, Kikuchi H, Osano M, Takane K, Okazaki T, Seo T, Okubo Y, Yamaguchi H . Monoclonal antibodies against human erythrocyte membrane antigens and the antigens recognized by these antibodies Acta Haematol Jpn 1989 52: 561–566
Inukai T, Sugita K, Iijima K, Tezuka T, Goi K, Kojika S, Shiraishi K, Kagami K, Nakazawa S . Expression of granulocyte colony-stimulating factor receptor on CD10-positive human B-cell precursors Br J Haematol 1995 89: 623–626
Stewart C . Methods for studying the ontogeny of mononuclear phagocytes. In: Weir DM (ed) Handbook of Experimental Immunology. Volume 2: Cellular Immunology Blackwell Scientific Publications: Oxford 1986 pp 44.15–44.16
Kamachi S, Matsubara K, Kobayashi T, Motojima H, Shimane M, Mizuno K, Fukushima M . Preparation and characteristics of anti-recombinant human G-CSF antibodies Jpn Pharmacol Ther 1990 18: 2221–2226
Motojima H, Kobayashi T, Shimane M, Kamachi S, Fukushima M . Quantitative enzyme immunoassay for human granulocyte colony-stimulating factor J Immunol Meth 1989 118: 187–191
Kiriyama R, Chichibu K, Matsuno T, Ohsawa N . Sensitive chemiluminescent immunoassay for human granulocyte colony-stimulating factor in clinical applications Clin Chim Acta 1993 220: 201–209
Layton JE, Hockman H, Sheridan WP, Morstyn G . Evidence for a novel in vivo control mechanism of granulopoiesis: mature cell-related control of a regulatory growth factor Blood 1989 74: 1303–1308
Mole JV . The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype Blood 1996 88: 2375–2382
Bedi A, Zehnbauer BA, Barber JP, Sharkis SJ, Jones RJ . Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia Blood 1994 83: 2038–2044
Daley GQ, Baltimore D . Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific p210bcr/abl protein Proc Natl Acad Sci USA 1988 85: 9312–9316
de Lau WBM, Hurenkamp J, Berendes P, Touw IP, Clevers HC, van Dijk MA . The gene encoding the granulocyte colony-stimulating factor receptor is a target for deregulation in pre-B ALL by the t(1;19)-specific oncoprotein E2A-Pbx1 Oncogene 1998 17: 503–510
Larsen A, David T, Curtis BM, Gimpel S, Sims JE, Cosman D, Park L, Sorensen E, March CJ, Smith CA . Expression cloning of a human granulocyte colony-stimulating factor receptor: a structural mosaic of hematopoietin receptor, immunoglobulin, and fibronectin domains J Exp Med 1990 172: 1559–1570
Kita K, Nishi K, Oishi K, Morita N, Takakura N, Kawakami K, Miwa H, Shirakawa S . Frequent gene expression of granulocyte colony-stimulating factor (G-CSF) receptor in CD7+ surface CD3−-acute lymphoblastic leukemia Leukemia 1993 7: 1184–1190
Fukunaga R, Ishizaka-Ikeda E, Nagata S . Growth and differentiation signals mediated by the cytoplasmic domain of granulocyte colony-stimulating factor receptor Cell 1993 74: 1079–1085
Yoshikawa A, Murakami H, Nagata S . Distinct signal transduction through the tyrosine-containing domains of the granulocyte colony-stimulating factor receptor EMBO J 1995 14: 5288–5294
Murohashi I, Tohda S, Suzuki T, Nagata K, Yamashita Y, Nara N . Autocrine growth mechanisms of the progenitors of blast cells in acute myeloblastic leukemia Blood 1989 74: 35–41
Nocola NA . Down-modulation of receptors for granulocyte colony stimulating factor on human neutrophils by granulocyte-activating agents J Cell Physiol 1986 128: 501–509
Klein H, Becher R, Lubbert M, Oster W, Schleiermacher E, Brach MA, Souza L, Lindemann A, Mertsmann RH, Herrmann F . Synthesis of granulocyte colony-stimulating factor and its requirement for terminal division in chronic myelogenous leukemia J Exp Med 1990 171: 1785–1790
Jiang X, Lopez A, Holyoake T, Eaves A, Eaves C . Autocrine production and action of IL-3 and granulocyte colony-stimulating factor in chronic myeloid leukemia Proc Natl Acad Sci USA 1999 96: 12804–12809
Laneuville P, Heisterkamp N, Groffen J . Expression of the chronic myelogenous leukemia-associated p210bcr/abl oncoprotein in a murine IL-3 dependent myeloid cell line Oncogene 1991 6: 275–281
Sirard C, Laneuville P, Dick JE . Expression of bcr-abl abrogates factor-dependent growth of human hematopoietic M07E cells by an autocrine mechanism Blood 1994 83: 1575–1585
Ohno R, Naoe T, Kanamaru A, Yoshida M, Hiraoka M, Kobayashi T, Ueda T, Minami S, Morishima Y, Saito Y, Furusawa S, Imai K, Takemoto Y, Miura Y, Teshima H, Hamajima N . Kohseisho Leukemia Study Group. A double-blind controlled study of granulocyte colony-stimulating factor started 2 days before induction chemotherapy in refractory acute myeloid leukemia Blood 1994 83: 2086–2093
Estey EH . Use of colony-stimulating factors in the treatment of acute myeloid leukemia Blood 1994 83: 2015–2019
Acknowledgements
We thank Kris Dittmer for critical reading of the manuscript, and Chugai Pharmaceutical (Tokyo, Japan) for measuring the intracellular G-CSF.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Inukai, T., Sugita, K., Mitsui, K. et al. Participation of granulocyte colony-stimulating factor in the growth regulation of leukemia cells from Philadelphia chromosome-positive acute leukemia and blast crisis of chronic myeloid leukemia. Leukemia 14, 1386–1395 (2000). https://doi.org/10.1038/sj.leu.2401837
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2401837
Keywords
This article is cited by
-
A novel, polymer-coated oncolytic measles virus overcomes immune suppression and induces robust antitumor activity
Molecular Therapy - Oncolytics (2016)
-
Glucocorticoid-induced granzyme A expression can be used as a marker of glucocorticoid sensitivity for acute lymphoblastic leukemia therapy
Journal of Human Genetics (2007)
-
The JAK2 inhibitor AG490 predominantly abrogates the growth of human B-precursor leukemic cells with 11q23 translocation or Philadelphia chromosome
Leukemia (2001)
-
Expression of thrombopoietin receptor and its functional role in human B-precursor leukemia cells with 11q23 translocation or Philadelphia chromosome
Leukemia (2000)